Gaxiola-Flores M, Herrera-Paredes JM, Álvarez-Aguirre A, Ruiz-Recendiz MJ

Language: Spanish
References: 18
Page: 105-115
PDF size: 1773.56 Kb.

ABSTRACT

Introduction: When a person is diagnosed with type 2 diabetes mellitus (T2DM), this news usually represents a set of emotions, such as stress, anxiety, and uncertainty about the disease. This puts the person in a difficult position, due to their inability to predict the results.
Objective: To carry out a state-of-the-art review, from 2011 to 2016, on the effects of uncertainty in adults with T2DM.
Methods: Based on the stages proposed by Dal Sasso-Mendes, the review was performed in the following databases: Ebsco, PubMed, SciELO, Conricyt, ScienceDirect, and Scopus. Two health sciences descriptors were used in English, Spanish and Portuguese: Diabetes Mellitus, Type 2, and Diabetes Mellitus Tipo 2 (for Spanish and Portuguese), as well as Uncertainty, Incertidumbre, and Incerteza. 2721 articles were identified, out of which 23 that met the selection criteria were selected.
Results: From the different components of uncertainty and T2DM, four were formed: theoretical, social support, emotional responses, and differences in treatment. It was identified a relation between theoretical and social support components (21.7%) with uncertainty, with greater emphasis in the differences in treatment component (43.5%).
Conclusion: It was identified that the effect of uncertainty on patients facing T2DM is a relatively unresearched situation, mainly concerning emotional responses.

REFERENCES

1. Al Quwaidhi AJ, Pearce MS, Sobngwi E, Critchley JA, O’Flaherty M. Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies. Diabetes Res Clin Pract. 2014;103(3): 496-503. 2

2. Organización Mundial de la Salud. Informe Mundial sobre la Diabetes. Ginebra, Suiza: OMS; 2016. Disponible en https://apps.who.int/iris/bitstream/handle/10665/254649/9 789243565255-spa.pdf?sequence=1

3. International Diabetes Federation. IDF Diabetes Atlas. Eight edition 2017. [Sin lugar de publicación]: IDF; 2017. Disponible en http://fmdiabetes.org/wp-content/uploads/ 2018/03/IDF- 2017.pdf

4. Ledesma-Delgado ME, Oros-Elizarraras E, Ávila-Sansores GM, Ruvalcaba-Palacios G. Respuestas emocionales de las mujeres que viven con diabetes mellitus tipo 2. Rev Enferm Inst Mex Seguro Soc. 2014;22(2):85-92.

5. Rondón JE, Lugli Z. Efectos del tipo de diabetes, estrategias de afrontamiento, sexo, optimismo en el apoyo social. Revista de Psicopatología y Psicología Clínica. 2013;18(3):193-207.

6. Gómez-Palencia IP, Castillo-Avila IY, Alvis-Estrada LR. Incertidumbre en adultos diabéticos tipo 2 a partir de la teoría de Merle Mishel. Aquichan. 2015;15(2):210-8.

7. Dal Sasso Mendes K, de Campos Pereira Silveira RC, Galvão CM. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm. 2008;17(4):758-64.

8. Stetler CB, Morsi D, Rucki S, Broughton S, Corrigan B, Fitzgerald J, et al. Utilization-focused integrative reviews in a nursing service. Appl Nurs Res. 1998;11(4):195-206.

9. Wilke T, Groth A, Fuchs A, Seitz L, Kienho J, Lundershausen R, et al. Real life treatment of diabetes mellitus type 2 patients: An analysis based on a large sample of 394,828 German patients. Diabetes Research and Clinical Practice. 2014;106(2):275-85.

10. Barker A, Langenberg C, Wareham NJ. Genetic determinants of glucose homeostasis. Best Pract Res Clin Endocrinol Metab. 2012;26(2):159-70.

11. Sathananthan A, Dalla-Man C, Zinsmeister AR, Camilleris M, Rodeheffer RJ, Toffolo G, et al. A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. Clinical Endocrinology. 2011;76(2):212-9.

12. Pinzón-Rocha ML, Aponte-Garzón LH, Hernández-Páez RF. Experiencia de los cuidadores informales en el manejo de la diabetes mellitus tipo II. ORINOQUIA. 2012;17(2):241-51. 4

13. Trejo-Martínez F. Incertidumbre ante la enfermedad. Aplicación de la teoría para el cuidado enfermero. Enf Neurol (Mex). 2012; 11(1):34-38.

14. Evans M, Wolden M, Gundgaard J, Chubb B, Christensen T. Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin – from the UK health care cost perspective. Diabetes, Obesity and Metabolism. 2014;16 (4):366-75.

15. Lehrke M, Leiter LA, Hehnke U, Thiemann S, Bhandari A, Meinicke T, et al. Safety and efficacy of linagliptin in patients with type 2 diabetes mellitus and coronary artery disease: Analysis of pooled events from 19 clinical trials. J Diabetes Complications. 2016;30(7):1378-84.

16. Guyatt GH, Málaga G. Dificultades en la Interpretación de los resultados de la Investigación biomedica relacionada con el manejo de pacientes con Enfermedades Cronicas No Transmisibles. Revista Peruana de Medicina Experimental y Salud Pública. 2013;31(1):127-30.

17. Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Soo L. Hyperglycemia Is Associated with Impaired Muscle Quality in Older Men with Diabetes: The Korean Longitudinal Study on Health and Aging. Diabetes Metab Journal. 2016;40(2): 140-6.

18. Guillén-Velasco RC. La connotación de persona en situación de cronicidad. Enferm Univ. 2012;9(3):44-56.